- Home
- AIP
AIP
Arteris Inc.
as of 03-06-2026 3:56pm EST
Arteris Inc is a provider of semiconductor system IP, including interconnect and other intellectual property, (collectively, System IP) technology. Its IP technology manages the on-chip communications and IP block deployments in System-on-Chip (SoC) semiconductors and systems of chiplets. Its proprietary System IP solutions achieve this by connecting client IP blocks such as processors, memories, artificial intelligence/machine learning (AI/ML) accelerators, graphics subsystems, safety and security, and other input/output subsystems (I/Os) via multiple Network-on-Chips (NoCs). The company operates in Americas, Asia Pacific and Europe, Middle East, out of which it derives maximum profit from Asia Pacific.
| Founded: | 2003 | Country: | United States |
| Employees: | N/A | City: | CAMPBELL |
| Market Cap: | 767.5M | IPO Year: | 2021 |
| Target Price: | $16.83 | AVG Volume (30 days): | 492.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.82 | EPS Growth: | 4.65 |
| 52 Week Low/High: | $5.64 - $19.85 | Next Earning Date: | N/A |
| Revenue: | $70,579,000 | Revenue Growth: | 22.27% |
| Revenue Growth (this year): | 30.24% | Revenue Growth (next year): | 19.50% |
| P/E Ratio: | -18.93 | Index: | N/A |
| Free Cash Flow: | 5.3M | FCF Growth: | N/A |
AI-Powered AIP Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Arteris Inc. (AIP)
Director
Avg Cost/Share
$17.02
Shares
3,690
Total Value
$62,786.46
Owned After
390,000
SEC Form 4
Director
Avg Cost/Share
$17.21
Shares
106,031
Total Value
$1,825,079.79
Owned After
390,000
SEC Form 4
Director
Avg Cost/Share
$17.01
Shares
11,762
Total Value
$200,046.92
Owned After
390,000
SEC Form 4
Director
Avg Cost/Share
$17.14
Shares
73,610
Total Value
$1,261,793.18
Owned After
390,000
SEC Form 4
Director
Avg Cost/Share
$17.00
Shares
4,907
Total Value
$83,419.49
Owned After
390,000
SEC Form 4
President and CEO
Avg Cost/Share
$15.03
Shares
2,756
Total Value
$41,428.74
Owned After
9,349,071
SEC Form 4
10% Owner
Avg Cost/Share
$15.03
Shares
2,756
Total Value
$41,428.74
Owned After
9,349,071
SEC Form 4
President and CEO
Avg Cost/Share
$15.21
Shares
47,244
Total Value
$718,359.19
Owned After
9,349,071
SEC Form 4
10% Owner
Avg Cost/Share
$15.21
Shares
47,244
Total Value
$718,359.19
Owned After
9,349,071
SEC Form 4
VP and General Counsel
Avg Cost/Share
$15.48
Shares
5,000
Total Value
$77,376.50
Owned After
57,650
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| RAZA SAIYED ATIQ | AIP | Director | Mar 4, 2026 | Sell | $17.02 | 3,690 | $62,786.46 | 390,000 | |
| RAZA SAIYED ATIQ | AIP | Director | Mar 2, 2026 | Sell | $17.21 | 106,031 | $1,825,079.79 | 390,000 | |
| RAZA SAIYED ATIQ | AIP | Director | Feb 27, 2026 | Sell | $17.01 | 11,762 | $200,046.92 | 390,000 | |
| RAZA SAIYED ATIQ | AIP | Director | Feb 26, 2026 | Sell | $17.14 | 73,610 | $1,261,793.18 | 390,000 | |
| RAZA SAIYED ATIQ | AIP | Director | Feb 25, 2026 | Sell | $17.00 | 4,907 | $83,419.49 | 390,000 | |
| JANAC K CHARLES | AIP | President and CEO | Feb 10, 2026 | Sell | $15.03 | 2,756 | $41,428.74 | 9,349,071 | |
| Bayview Legacy, LLC | AIP | 10% Owner | Feb 10, 2026 | Sell | $15.03 | 2,756 | $41,428.74 | 9,349,071 | |
| JANAC K CHARLES | AIP | President and CEO | Feb 9, 2026 | Sell | $15.21 | 47,244 | $718,359.19 | 9,349,071 | |
| Bayview Legacy, LLC | AIP | 10% Owner | Feb 9, 2026 | Sell | $15.21 | 47,244 | $718,359.19 | 9,349,071 | |
| Alpern Paul L | AIP | VP and General Counsel | Feb 2, 2026 | Sell | $15.48 | 5,000 | $77,376.50 | 57,650 |
Earnings Transcripts
SEC 8-K filings with transcript text
2025 Q4 Q4 2025 Earnings
8-K SELL Feb 12, 2026 · 43% conf.
Q4 2025 Earnings
8-K SELLFeb 12, 2026 · 43% conf.
1D
-4.17%
$14.32
5D
-7.65%
$13.80
20D
-8.12%
$13.73
aip-20260212FALSE000166701100016670112026-02-122026-02-12
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (date of earliest event reported): February 12, 2026
ARTERIS, INC.
(Exact name of Registrant, as specified in its charter)
Delaware001-4096027-0117058 (State or other jurisdiction of incorporation)(Commission File Number)(I.R.S. Employer Identification Number)
900 E. Hamilton Ave., Suite 300 Campbell, CA 95008 (Address of principal executive offices, including Zip code)
Registrant's telephone number, including area code: (408) 470-7300
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.001 par value per share AIP The Nasdaq Stock Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☒ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On February 12, 2026, Arteris, Inc. (the “Company”) issued a press release announcing its financial results for the fourth quarter and full year ended December 31, 2025. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
The information contained in this Item 2.02 and Item 9.01 of this Current Report on Form 8-K, including the accompanying Exhibit 99.1 hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filings, unless expressly incorporated by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit No.Description 99.1 Press Release dated February 12, 2026
104Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document).
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: February 12, 2026
By:/s/ Nicholas B. Hawkins Name:Nicholas B. Hawkins Title:Vice President and Chief Financial Officer (Principal Financial and Accounting Officer)
3
2025 Q3 Q3 2025 Earnings
8-K Nov 4, 2025
Q3 2025 Earnings
8-KNov 4, 2025
aip-20251104FALSE000166701100016670112025-11-042025-11-04
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (date of earliest event reported): November 4, 2025
ARTERIS, INC.
(Exact name of Registrant, as specified in its charter)
Delaware001-4096027-0117058 (State or other jurisdiction of incorporation)(Commission File Number)(I.R.S. Employer Identification Number)
900 E. Hamilton Ave., Suite 300 Campbell, CA 95008 (Address of principal executive offices, including Zip code)
Registrant's telephone number, including area code: (408) 470-7300
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.001 par value per share AIP The Nasdaq Stock Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☒ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On November 4, 2025, Arteris, Inc. (the “Company”) issued a press release announcing its financial results for the quarter ended September 30, 2025. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
The information contained in this Item 2.02 and Item 9.01 of this Current Report on Form 8-K, including the accompanying Exhibit 99.1 hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filings, unless expressly incorporated by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit No.Description 99.1 Press Release dated November 4, 2025
104Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document).
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: November 4, 2025
By:/s/ Nicholas B. Hawkins Name:Nicholas B. Hawkins Title:Vice President and Chief Financial Officer (Principal Financial and Accounting Officer)
3
2025 Q2 Q2 2025 Earnings
8-K Aug 5, 2025
Q2 2025 Earnings
8-KAug 5, 2025
aip-20250805FALSE000166701100016670112025-08-052025-08-05
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (date of earliest event reported): August 5, 2025
ARTERIS, INC.
(Exact name of Registrant, as specified in its charter)
Delaware001-4096027-0117058 (State or other jurisdiction of incorporation)(Commission File Number)(I.R.S. Employer Identification Number)
900 E. Hamilton Ave., Suite 300 Campbell, CA 95008 (Address of principal executive offices, including Zip code)
Registrant's telephone number, including area code: (408) 470-7300
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.001 par value per share AIP The Nasdaq Stock Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☒ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On August 5, 2025, Arteris, Inc. (the “Company”) issued a press release announcing its financial results for the quarter ended June 30, 2025. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
The information contained in this Item 2.02 and Item 9.01 of this Current Report on Form 8-K, including the accompanying Exhibit 99.1 hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filings, unless expressly incorporated by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit No.Description 99.1 Press Release dated August 5, 2025
104Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document).
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: August 5, 2025
By:/s/ Nicholas B. Hawkins Name:Nicholas B. Hawkins Title:Vice President and Chief Financial Officer (Principal Financial and Accounting Officer)
3
Compare AIP vs Leading Stocks
See how AIP stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "AIP Arteris Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.